skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Guidelines Panel Members

(Last updated: August 6, 2015; last reviewed: August 6, 2015)

Members of the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission

Revisions to the March 28, 2014, Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal Transmission in the United States have been made by the Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (a Working Group of the Office of AIDS Research Advisory Council).

Members of the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
Members of the Panel
Erika Aaron, MSN, ANP, CRNP Drexel University College of Medicine, Philadelphia, PA
Elaine J. Abrams, MD Columbia University, New York, NY
Jean Anderson, MD Johns Hopkins University School of Medicine, Baltimore, MD
Liz Barr, MA, MS Madison, WI
Brookie M. Best, PharmD, MAS University of California San Diego, La Jolla, CA and Rady Children’s Hospital-San Diego, CA
Andrea Ciaranello, MD, MPH Massachusetts General Hospital, Harvard Medical School, Boston, MA
Rana Chakraborty, MD, MS, PhDa Emory University School of Medicine, Atlanta, GA
Susan E. Cohn, MD, MPH Northwestern University Feinberg School of Medicine, Chicago, IL
Susan Cu-Uvin, MD Alpert School of Medicine, Brown University, Providence, RI
Stephanie Deyo Seattle, WA
Judith Feinberg, MD University of Cincinnati College of Medicine, Cincinnati, OH
Patricia M. Flynn, MD St. Jude Children’s Research Hospital, Memphis, TN
Gweneth B. Lazenby, MD, MSCR Medical University of South Carolina, Charleston, SC
Judy Levison, MD, MPH Baylor College of Medicine, Houston, TX
Robert T. Maupin, MD Louisiana State University Health Sciences Center, New Orleans, LA
Howard Minkoff, MDb Maimonides Medical Center, State University of New York Brooklyn, Brooklyn, NY
Mark Mirochnick, MD Boston Medical Center, Boston University of Medicine, Boston, MA
Lynne M. Mofenson, MD Elizabeth Glaser Pediatric AIDS Foundation, Washington DC
Fatima Y. Prioleau, MA Brooklyn, NY
Stephen A. Spector, MD University of California, San Diego, La Jolla, CA and Rady Children's Hospital- San Diego, San Diego, CA
Kathleen E. Squires, MD Thomas Jefferson University, Philadelphia, PA
Meg Sullivan, MD Boston Medical Center, Boston, MA
Ruth Tuomala, MD Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Geoffrey A. Weinberg, MD
University of Rochester School of Medicine and Dentistry, Rochester, NY
Panel Executive Secretary
George K. Siberry, MD, MPH
National Institutes of Health, Rockville, MD
Ex Officio Member
Deborah Cohan, MD
National Perinatal HIV Hotline, San Francisco, CA
Members from the Department of Health and Human Services
Nahida Chakhtoura, MD, MsGH National Institutes of Health, Rockville, MD
Brian Feit, MPA Health Resources and Services Administration, Rockville, MD
Devasena Gnanashanmugam, MD National Institutes of Health, Bethesda, MD
Denise Jamieson, MD, MPH Centers for Disease Control and Prevention, Atlanta, GA
Steve Nesheim, MD Centers for Disease Control and Prevention, Atlanta, GA
Polly E. Ross, MD Health Resources and Services Administration, Rockville, MD
Alan Shapiro, MD, PhD Food and Drug Administration, Rockville, MD
D. Heather Watts, MD
Office of Global AIDS Coordinator and Health Diplomacy, Washington, DC
Non-Voting Observers from the François-Xavier Bagnoud Center
Deborah Storm, MSN, PhD François-Xavier Bagnoud Center, School of Nursing, Rutgers, The State University of New Jersey, Newark, NJ
a American Academy of Pediatrics Committee on Pediatric AIDS liaison
b American Congress of Obstetricians and Gynecologists liaison

 

Special Thanks

We would like to acknowledge and recognize the contributions of Carolyn Burr, RN, EdD, who is retiring from the Panel on Treatment of HIV-Infected Pregnant Woman and Prevention of Perinatal Transmission and the Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. As a nurse practitioner, educator, and former Deputy Director of the François-Xavier Bagnoud Center at the School of Nursing, Rutgers, The State University of New Jersey, Dr. Burr was one of the early champions for comprehensive pediatric HIV care and perinatal HIV prevention in the United States and has provided key leadership and support for both the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection and the Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States since their inception. 

Back to Top